LivaNova (Nasdaq:LIVN) announced today that it received FDA premarket approval (PMA) for its aura6000 neuromodulation system for sleep apnea.
Add Yahoo as a preferred source to see more of our stories on Google. Photo Credit: iStock A visit to a water treatment plant inspired a pair of Texas teenagers to develop a device to filter one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results